Advances in Pharmacogenomic Approaches to Precision Medicine

July 29, 2021

Course description

Can doctors predict in advance whether a treatment will work for an individual patient? Or whether it might cause serious side effects? Techniques that harness the power of DNA technology and point-of-care prescribing decision support are now making this possible in the field of pharmacogenomics.

Join us as Dr. Peter O’Donnell discusses these advancements, including several examples of current clinical settings and models that utilize genomic information to tailor prescribing. Dr. O’Donnell will argue that, in the current age of precision medicine, the pertinent question might instead be: why don’t more doctors use such information already?

Learning objectives

At the conclusion of this learning activity, participants will be able to:

  • Summarize current evidence for how genomic information can inform the prescribing of commonly used drugs
  • Illustrate current applications of the implementation of genomic information in clinical settings to tailor prescribing
  • Identify potential barriers to more widespread use of genomics to inform prescribing

Target audience

Physician and clinician policyholders

Disclosure

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.

CME information

ISMS logo This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Illinois State Medical Society and ISMIE Mutual Insurance Company. The Illinois State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

The Illinois State Medical Society designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Illinois Nurse Practice Act rules deem CME credit provided by approved sponsors as acceptable to fulfill nursing continuing education requirements for licensure. Nurses may claim one contact hour per unit of CME in the state of Illinois.

Additional information

Estimated time for completion: 
1 hour
Disclaimer: 

The recommendations contained in this resource are not intended to define conduct that is appropriate in every case, should not be considered as establishing any standard of care, and do not constitute legal advice. Physicians, clinicians and healthcare providers should take care to ensure that all care rendered reflects the best clinical judgment and complies with the laws and regulations of the state or location at which the care was provided.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Illinois State Medical Society and ISMIE Mutual Insurance Company. The Illinois State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

    The Illinois State Medical Society designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Discount Credit
  • 1.00 Participation Credit
Course opens: 
06/23/2021
Course expires: 
08/12/2021
Event starts: 
07/29/2021 - 12:00pm
Event ends: 
07/29/2021 - 1:00pm
Add to calendar: 
Rating: 
0

Peter H. O’Donnell, MD

Peter O'DonnellPeter H. O’Donnell, MD, is a physician-scientist with advanced training in clinical pharmacology and a practicing medical oncologist specializing in the treatment of genitourinary malignancies, specifically bladder cancer. His research focuses on elucidation of germline genetic markers that predict medication response (pharmacogenomics).

Dr. O’Donnell’s work explores facilitating and understanding the delivery and adoption of genomic information at the point of care to inform prescribing. He is especially interested in assessing whether the critical mass of clinically actionable germline pharmacogenomic information can be utilized in practice if barriers to implementation can be overcome. He was PI of “The 1200 Patients Project”, an NIH-funded clinical research study that examined how preemptive pharmacogenomic test results could be incorporated into treatment decisions. Dr. O’Donnell was also Translational Project Lead for a multi-institutional cooperative agreement (NIH U54) examining pharmacogenomic implementation questions for hospitalized minority patients. He additionally currently leads a large institutional project examining pharmacogenomic utilization during perioperative/critical care and pain management through another NIH-funded study (R01), and is also exploring pharmacogenomic utilization to reduce adverse events among oncology patients.

Available Credit

  • 1.00 AMA PRA Category 1 Credits™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Illinois State Medical Society and ISMIE Mutual Insurance Company. The Illinois State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

    The Illinois State Medical Society designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Discount Credit
  • 1.00 Participation Credit
Please login to access.

 

Employed by a policyholder, but don't have an ISMIE web account? You can still register for the webinar here.